| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008040550A2 Olive extracts for promoting muscle health |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085323 Promotes myoblast differentiation based on identification of cellular processes affected by prelamin A processing |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1907405A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 04/09/2008 | EP1450796B1 Benzothiazole derivatives |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1124551B1 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/08/2008 | US7355047 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/03/2008 | WO2008039085A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | WO2008038771A1 Glutamine-containing composition for increasing blood flow |
| 04/03/2008 | WO2008038644A1 Agent for preventing development of reflex sympathetic dystrophy after stroke |
| 04/03/2008 | WO2008037258A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 04/03/2008 | US20080081785 Paralytic Peptide For Use In Neuromuscular Therapy |
| 04/03/2008 | US20080081784 Administering to the cell a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake |
| 04/03/2008 | US20080081355 Activatable recombinant neurotoxins |
| 04/03/2008 | CA2664744A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | CA2664258A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 04/02/2008 | EP1905771A2 Quinuclidine derivatives and their use |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | CN100378090C Substituted dioxopentacyclic derivative and its use in preparing neuro regulator |
| 04/02/2008 | CN100377714C Application of steroidal sapogenins and their derivatives in medicine preparation |
| 04/01/2008 | US7351736 Therapeutic compositions (II) |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351686 Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
| 04/01/2008 | CA2446574C Liquid pharmaceutical composition |
| 03/27/2008 | WO2008035001A2 Composition for the treatment of amyotrophic lateral sclerosis |
| 03/27/2008 | WO2008034832A1 Compositions comprising a statin and caffeine for the treatment of viral infection |
| 03/27/2008 | WO2007071363A3 METHODS OF USING THE CALCINEURIN A VARIANT Cnaβ1 |
| 03/27/2008 | US20080076823 Methods of improving bone health and muscle health |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076769 Norvaline Derivative and Method for Preparation Thereof |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | DE102006042742A1 Nano-Vehikel für den transkutanen Transport, diese enthaltende Zubereitungen und deren Anwendung Nano vehicle for transcutaneous delivery, compositions containing them and their use |
| 03/27/2008 | CA2663272A1 Composition for the treatment of amyotrophic lateral sclerosis |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/20/2008 | WO2008031212A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/20/2008 | WO2001025398A3 Process for inducing functional tolerance to gene transfer products |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070990 Use of ractopamine enantiomers |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070866 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/19/2008 | EP1900811A1 Enriched central nervous system cell populations |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | CN101146546A Muscle regeneration |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |
| 03/19/2008 | CN101143192A Therapeutic gastrodia extracts |
| 03/19/2008 | CN101143147A Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 03/18/2008 | US7345138 Biodegradable polyphosphates for controlled release of bioactive substances |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | CA2335015C Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 03/18/2008 | CA2275663C Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence |
| 03/14/2008 | CA2613119A1 Compositions and methods for enhancing accretion in skeletal muscle |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029168A2 Treatment of duchenne muscular dystrophy |
| 03/13/2008 | WO2008029152A2 Treatment of duchenne muscular dystrophy |
| 03/13/2008 | WO2008028888A2 Use of cripto-1 or cripto-3 for the treatment of skeletal muscle wasting |
| 03/13/2008 | WO2007113540A3 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 03/13/2008 | US20080064739 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/13/2008 | US20080064738 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 03/13/2008 | US20080064737 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 03/13/2008 | US20080063732 Tetanus toxin, conotoxin, curare, botulinum toxin, aluminum chloride, glycopyrrolate, robinol; treat facial rhytides, hyperhidrosis, muscle, sweat gland hyperactivity condition; collagen, hydrogel, dextran, hyaluronic acid, epinephrine diffusion-limiting agent, anti-metabolic agent |
| 03/13/2008 | CA2662480A1 Methods and compositions for the treatment of antibody mediated neuropathies |
| 03/13/2008 | CA2661836A1 Anti-myostatin antibodies |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897948A1 Mammalian transforming growth factor beta 9 |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 03/12/2008 | CN100374465C Neutralizing antibodies against GDF-8 and uses therefor |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/12/2008 | CN100374161C Triacetin as a transdermal penetration enhancer |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | CA2612595A1 Compositions and methods affecting heat shock protein expression for improved muscle building |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |